Emotra AB (publ) (”Emotra”) meddelar idag att bolagets årsredovisning avseende räkenskapsåret 2020 och övriga handlingar... 210429 - Emotra- PM - Årsredovisning 2020 och handlingar inför stämman
At this year’s regular shareholder meeting, Emotra AB (“Emotra” or “the Company”) will propose the nomination of Ingela Hallberg as a new director. 210422 - Emotra- PM - Board changes
After a period of negotiations between Emotra and the Japanese company Beauty Life Corporation (BLC), the two companies have signed a letter of intent. 210415 - Emotra - PM - Emotra signs Letter Of Intent with BLC
Efter en tids diskussioner mellan Emotra och det japanska bolaget Beauty Life Corporation (BLC) har nu en avsiktsförklaring, så kallat Letter Of Intent, tecknats. 210415 - Emotra - PM - Emotra signerar avsiktsförklaring med BLC
The Board and CEO of Emotra AB herewith present the year-end report for the financial year 2020. 210224 Year-end report 2020 EN
An article on the first study on the connection between hyporeactivity and increased risk of depression relapse has been published... 210215 - Emotra- PM - Publication in BMC Psychiatry
As for many other companies, the Covid-19 situation has been challenging for Emotra. 201229 - Emotra - PM - Emotra, overview for 2021
Today, Emotra is proud to announce that a manuscript that reports the findings from our first study.... 201221 - Emotra- PM - First relapse study accepted for publication in BMC Psychiatry
The Board of Directors and the CEO of Emotra AB hereby present the interim report for the first nine months of 2020. 201126 Interim report Jan- Sept 2020
Notice is hereby given that an extraordinary general meeting of shareholders in Emotra AB (publ), 556612-1579, will be held at 11 am on Friday December 4.... 201120 - Emotra- PM - Notice of EGM
